136 related articles for article (PubMed ID: 7786956)
1. Estrogen augments serotonergic activity in postmenopausal women.
Halbreich U; Rojansky N; Palter S; Tworek H; Hissin P; Wang K
Biol Psychiatry; 1995 Apr; 37(7):434-41. PubMed ID: 7786956
[TBL] [Abstract][Full Text] [Related]
2. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.
Garcia-Borreguero D; Jacobsen FM; Murphy DL; Joseph-Vanderpool JR; Chiara A; Rosenthal NE
Biol Psychiatry; 1995 May; 37(10):740-9. PubMed ID: 7640329
[TBL] [Abstract][Full Text] [Related]
3. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
[TBL] [Abstract][Full Text] [Related]
5. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
[TBL] [Abstract][Full Text] [Related]
6. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
[TBL] [Abstract][Full Text] [Related]
8. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Biol Psychiatry; 1997 Jun; 41(11):1071-86. PubMed ID: 9146818
[TBL] [Abstract][Full Text] [Related]
9. Estrogen replacement therapy and the estraderm transdermal system.
Youngkin EQ
Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
[TBL] [Abstract][Full Text] [Related]
10. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
11. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
[TBL] [Abstract][Full Text] [Related]
12. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement therapy with transdermal estradiol lowers insulin-cortisol and lipoproteins levels in postmenopausal women].
Basurto L; Saucedo R; Ochoa R; Hernández M; Zárate A
Ginecol Obstet Mex; 2002 Oct; 70():491-5. PubMed ID: 12557803
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine.
Stein DJ; Hollander E; Cohen L; Simeon D; Aronowitz B
Biol Psychiatry; 1995 Mar; 37(6):414-6. PubMed ID: 7772651
[No Abstract] [Full Text] [Related]
15. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
16. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
17. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
Tsvetkov Ts; Tsvetkov K; Petkova U
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
[No Abstract] [Full Text] [Related]
18. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures.
Stein DJ; Hollander E; DeCaria CM; Simeon D; Cohen L; Aronowitz B
Biol Psychiatry; 1996 Sep; 40(6):508-13. PubMed ID: 8879471
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques.
Mook D; Felger J; Graves F; Wallen K; Wilson ME
Psychoneuroendocrinology; 2005 Apr; 30(3):273-83. PubMed ID: 15511601
[TBL] [Abstract][Full Text] [Related]
20. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
Maffei S; Del Ry S; Prontera C; Clerico A
Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
